Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A metaanalysis

ISSN： 2049-9434

Source： Biomedical Reports, Vol.3, Iss.2, 2015-01, pp. : 235-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis

By He Shiyao Tang Yu-hong Zhao Guobin Yang Xiaolong Wang Dehou Zhang Ye

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2095-2102

Springer Publishing Company

Access to resources Recommend Favorite

Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 607-612

Science Publishers

Access to resources Recommend Favorite

Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1921-1930

Spandidos Publications

Access to resources Recommend Favorite

Efficacy and safety of sitagliptin compared with sulfonylurea therapy in patients with type 2 diabetes showing inadequately controlled glycosylated hemoglobin with metformin monotherapy: A meta-analysis

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1528-1536

Spandidos Publications

Access to resources Recommend Favorite

Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus

Experimental and Therapeutic Medicine, Vol. 4, Iss. 1, 2012-01 ,pp. : 113-120

Spandidos Publications

Access to resources Recommend Favorite